Two New Medications Added to SGK Reimbursement List

In a recent announcement, Vedat Işıkhan, the Minister of Labor and Social Security in Turkey, revealed that two additional medications have been incorporated into the reimbursement list of the Social Security Institution (SGK). These medicines are specifically intended for use in advanced surgical procedures for newborns and children, as well as for the treatment of early-stage breast cancer. Işıkhan emphasized that one medication will be utilized in the treatment of early-stage breast cancer, which is crucial for improving patient outcomes at a critical time. The second medication added is designed to address a rare condition characterized by the involvement of the optic nerve, providing a vital treatment option for affected individuals. This decision reflects the Turkish government's commitment to enhancing healthcare provisions and ensuring that patients have access to necessary treatments. The inclusion of these medications in the SGK reimbursement list is expected to ease the financial burden on families and improve health services for vulnerable populations, particularly children and those diagnosed with severe health conditions.